News about Glòria Garrabou

Clínic-IDIBAPS participates in a study where a new type of Mitochondrial DNA Depletion-Deletion Syndrome has been discovered

The study describes how mutations in the GUK1 gene are responsible for causing this new form of Mitochondrial DNA Depletion-Deletion Syndrome (MDDS),1

Clínic Barcelona

Research June 30 2023

Researchers at IDIBAPS Hospital-Clínic Barcelona receive two grants from the Mutua Madrileña Foundation

One of the projects is coordinated by Glòria Garrabou, the head of the group Hereditary metabolic diseases and muscular diseases, and the other by Os1

Clínic Barcelona

Research April 17 2023

Clínic-IDIBAPS researchers validate a cellular model for the study of inclusion-body myositis

The study, published by the Journal of Cachexia, Sarcopenia and Muscle, concludes that skin fibroblast cultures derived from patients reproduce the g1

Clínic Barcelona

Research March 20 2023

Merger approved of two IDIBAPS groups, Hereditary metabolic diseases and Muscle research and mitochondrial function

On the retirement of Antònia Ribes, leader of the Hereditary metabolic diseases group, Glòria Garrabou, leader of the Muscle research and mitochondri1

News about Glòria Garrabou

Clínic-IDIBAPS participates in a study where a new type of Mitochondrial DNA Depletion-Deletion Syndrome has been discovered

Researchers at IDIBAPS Hospital-Clínic Barcelona receive two grants from the Mutua Madrileña Foundation

Clínic-IDIBAPS researchers validate a cellular model for the study of inclusion-body myositis

Merger approved of two IDIBAPS groups, Hereditary metabolic diseases and Muscle research and mitochondrial function

Subscribe to the Newsletter of Clínic